伊諾維奧製藥股票討論區

$伊諾維奧製藥(INO.US)$ INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
 • BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
 • Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
 • Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...

$伊諾維奧製藥(INO.US)$ Inovio Pharmaceuticals Inc - Pricing of an Underwritten Offering of 2.5 Mln Shares of Its Common Stock at an Offering Price of $7.693 per Share

$伊諾維奧製藥(INO.US)$ Inovio Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

$伊諾維奧製藥(INO.US)$ .. may chance pass 1plus by today?

$伊諾維奧製藥(INO.US)$ .. After FDA approval will be increas same like rocket

$伊諾維奧製藥(INO.US)$ … run fast ..reach to .7 by today

$伊諾維奧製藥(INO.US)$ chance to rise ? sell or buy?